LABTVSNIVF• 28 Days (Normalized)
LABT vs NIVF (Lakewood-Amedex Biotherapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Aug 31 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $1.78
-28.8%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
-56.3%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
+27.5 pts
LABT outperforming by 27.50 percentage points
LABTNIVF
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(17 dates)
| Date | LABT Price | LABT Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $1.78 | -28.80% | $0.59 | -56.30% | +27.50% |
| Sep 22, 2026 | $1.99 | -20.40% | $0.73 | -45.66% | +25.26% |
| Sep 21, 2026 | $2.05 | -18.00% | $0.72 | -46.67% | +28.67% |
| Sep 18, 2026 | $1.99 | -20.40% | $0.72 | -46.74% | +26.34% |
| Sep 17, 2026 | $1.86 | -25.60% | $0.72 | -47.04% | +21.44% |
| Sep 16, 2026 | $2.09 | -16.40% | $0.79 | -41.85% | +25.45% |
| Sep 15, 2026 | $2.17 | -13.20% | $0.84 | -37.78% | +24.58% |
| Sep 14, 2026 | $2.12 | -15.20% | $0.93 | -31.19% | +15.99% |
| Sep 11, 2026 | $2.22 | -11.20% | $1.06 | -21.48% | +10.28% |
| Sep 10, 2026 | $2.05 | -18.00% | $1.11 | -17.78% | -0.22% |
| Sep 09, 2026 | $2.32 | -7.20% | $1.10 | -18.52% | +11.32% |
| Sep 08, 2026 | $2.18 | -12.80% | $1.11 | -17.78% | +4.98% |
| Sep 04, 2026 | $1.88 | -24.80% | $1.14 | -15.56% | -9.24% |
| Sep 03, 2026 | $1.90 | -24.00% | $1.18 | -12.59% | -11.41% |
| Sep 02, 2026 | $2.07 | -17.20% | $1.21 | -10.37% | -6.83% |
Page 1 of 2